COO — The Cooper Companies, Inc.
$62.65
+$0.46 (+0.74%)
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Market Cap
$11.91B
Forward P/E
13.4x
52-Week Range
N/A
COO Price History
Revenue vs. Net Income
$4.1B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$434M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
5.9%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
3.0x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
8.9%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-0.2%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
